Acquisition Completed
Jasper Therapeutics acquisition of Kira Pharmaceuticals
Announced 16 Jul 2026
Advisers
- Target
- Kira Pharmaceuticals
- Acquirer
- Jasper Therapeutics
- Target based in
- United States
- Buyer based in
- United States
- Completed
- 16 Jul 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development
In the league tables
- M&A financial advisers, 2026 to date Piper Sandler #22 · H.C. Wainwright & Co. #87
- M&A financial advisers, completed, 2026 to date Piper Sandler #39 · H.C. Wainwright & Co. #56
- M&A legal advisers, 2026 to date DLA Piper #24 · Paul Hastings #33
- M&A legal advisers, completed, 2026 to date DLA Piper #16 · Paul Hastings #18
Similar deals
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Novo Nordisk stake in Orbis Medicines Sep 2026 · Biotech
- Eli Lilly and Company acquisition of Merida Biosciences Aug 2026 · US$2.9bn · Biotech
- Werewolf Therapeutics and Ambros Therapeutics merger Aug 2026 · US$500m · Biotech
Sources
- 16 Jul 2026 Press release (EX-99.1, exhibit), Announces Merger with Kira Pharmaceuticals sec.gov
